GLYCINOROM 80MG TAB 10 S

About

Gliclazide is a second-generation sulfonylurea oral hypoglycemic agent used in the management of type 2 diabetes mellitus. It primarily works by stimulating the beta cells of the pancreas to release insulin, particularly in the presence of glucose, thereby effectively lowering blood glucose levels. This action helps to improve glycemic control in patients whose blood sugar cannot be adequately managed through diet and exercise alone. Gliclazide 80mg is a standard-release formulation, which means it is absorbed and acts relatively quickly. It is an important component of a comprehensive diabetes management plan aimed at achieving target HbA1c levels. Beyond its insulinotropic effects, gliclazide also exhibits some extrapancreatic actions, including enhancing peripheral insulin sensitivity and reducing hepatic glucose production, contributing to its overall efficacy in controlling hyperglycemia and mitigating the risk of long-term diabetic complications.

Uses

• Management of type 2 diabetes mellitus.
• When diet and exercise are insufficient.
• To lower elevated blood glucose levels.
• As part of a comprehensive diabetes management plan.

Directions For Use

Take orally, usually once or twice daily, with meals, as directed by your physician. Swallow the tablet whole.

Benefits

• Effective reduction in blood glucose levels.
• Helps achieve target HbA1c.
• Stimulates natural insulin release.
• Reduces risk of long-term diabetic complications.
• Improves peripheral insulin sensitivity.
• Contributes to overall glycemic control.

Side Effects

• Hypoglycemia (low blood sugar)
• Gastrointestinal disturbances (nausea, diarrhea)
• Abdominal pain
• Skin rash or itching
• Headache
• Dizziness
• Weight gain
• Allergic reactions
• Liver enzyme elevation
• Blood dyscrasias (rare)
• Visual disturbances
• Fatigue

Safety Measures

• Alcohol - Alcohol can increase the risk of hypoglycemia when taken with gliclazide. It is advisable to limit or avoid alcohol consumption.
• Pregnancy - Gliclazide is generally not recommended during pregnancy. Insulin therapy is usually preferred. Consult your doctor.
• Breastfeeding - Gliclazide may pass into breast milk. It is generally not recommended during breastfeeding. Consult your doctor.
• Liver - Use with caution in patients with liver impairment as it can affect drug metabolism and increase hypoglycemia risk. Dose adjustment may be necessary.
• Kidney - Use with caution in patients with moderate to severe kidney impairment. Dose adjustment may be required to avoid drug accumulation and hypoglycemia.
• Lung - No direct specific contraindication for lung conditions, but severe respiratory illness may impact overall health and diabetes management.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.